BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 25524396)

  • 1. Effect of combined treatment with rosuvastatin and protein kinase Cβ2 inhibitor on angiogenesis following myocardial infarction in diabetic rats.
    Huang D; Wang FB; Guo M; Li S; Yan ML; Yu T; Wei M; Li JB
    Int J Mol Med; 2015 Mar; 35(3):829-38. PubMed ID: 25524396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats.
    Wang F; Huang D; Zhu W; Li S; Yan M; Wei M; Li J
    Int J Mol Med; 2013 Nov; 32(5):1037-46. PubMed ID: 24002353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.
    Zaitone SA; Abo-Gresha NM
    Eur J Pharmacol; 2012 Sep; 691(1-3):134-42. PubMed ID: 22732653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nitric oxide synthase mediates statin-induced restoration of vasa nervorum and reversal of diabetic neuropathy.
    Ii M; Nishimura H; Kusano KF; Qin G; Yoon YS; Wecker A; Asahara T; Losordo DW
    Circulation; 2005 Jul; 112(1):93-102. PubMed ID: 15983249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rosuvastatin enhances the protective effects of ischemic postconditioning on myocardial ischaemia-reperfusion injury in type 2 diabetic rat].
    CAI W; FANG J; CHEN ZY; LIN YL; WU LM; CHEN LL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2010 Sep; 38(9):814-8. PubMed ID: 21092651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin-regulated post-translational phosphoproteome in human umbilical vein endothelial cells.
    Huang B; Wu CH; Li FA; Liang SS; Shieh YH; Wang LD
    Kaohsiung J Med Sci; 2013 Jul; 29(7):347-52. PubMed ID: 23768697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved cardiac performance by rosuvastatin is associated with attenuations in both myocardial tumor necrosis factor-alpha and p38 MAP kinase activity in rats after myocardial infarction.
    Xu Y; Tang T; Ding Y; Yao R; Xie J; Liao M; Xiao H; Chen Y; Yu X; Fu M; Liao Y; Zhao G; Cheng X
    Am J Med Sci; 2010 Aug; 340(2):121-7. PubMed ID: 20588182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardioprotective effects of low-dose combination therapy with rosuvastatin and fasudil in the isolated rat heart.
    Wu N; Li W; Lv Y; Shu W; Jia D
    Pharmazie; 2014 Sep; 69(9):704-8. PubMed ID: 25272944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rosuvastatin on fibrinolytic system of human umbilical vein endothelial cells in vitro.
    He F; Zhao J; Guo R; Liang Y
    Am J Med Sci; 2014 Oct; 348(4):319-23. PubMed ID: 24694789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways.
    Zhang Z; Li S; Cui M; Gao X; Sun D; Qin X; Narsinh K; Li C; Jia H; Li C; Han Y; Wang H; Cao F
    Basic Res Cardiol; 2013 Mar; 108(2):333. PubMed ID: 23386286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin improves hepatopulmonary syndrome through inhibition of inflammatory angiogenesis of lung.
    Chang CC; Wang SS; Hsieh HG; Lee WS; Chuang CL; Lin HC; Lee FY; Lee SD; Huang HC
    Clin Sci (Lond); 2015 Sep; 129(6):449-60. PubMed ID: 25940601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HMG-CoA reductase inhibitor improves endothelial dysfunction in spontaneous hypertensive rats via down-regulation of caveolin-1 and activation of endothelial nitric oxide synthase.
    Suh JW; Choi DJ; Chang HJ; Cho YS; Youn TJ; Chae IH; Kim KI; Kim CH; Kim HS; Oh BH; Park YB
    J Korean Med Sci; 2010 Jan; 25(1):16-23. PubMed ID: 20052342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-dose rosuvastatin ameliorates lung ischemia-reperfusion injury via upregulation of endothelial nitric oxide synthase and inhibition of macrophage infiltration in rats with pulmonary hypertension.
    Matsuo S; Saiki Y; Adachi O; Kawamoto S; Fukushige S; Horii A; Saiki Y
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):902-9. PubMed ID: 25454916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy.
    Manucha W; Kurbán F; Mazzei L; Benardón ME; Bocanegra V; Tosi MR; Vallés P
    Eur J Pharmacol; 2011 Jan; 650(2-3):487-95. PubMed ID: 20940012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosuvastatin prevents endothelial cell death and reduces atherosclerotic lesion formation in ApoE-deficient mice.
    Enomoto S; Sata M; Fukuda D; Nakamura K; Nagai R
    Biomed Pharmacother; 2009 Jan; 63(1):19-26. PubMed ID: 18162361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The protective effect of rosuvastatin in human umbilical endothelial cells exposed to constant or intermittent high glucose.
    Piconi L; Corgnali M; Da Ros R; Assaloni R; Piliego T; Ceriello A
    J Diabetes Complications; 2008; 22(1):38-45. PubMed ID: 18191076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rosuvastatin reduces platelet activation in heart failure: role of NO bioavailability.
    Schäfer A; Fraccarollo D; Eigenthaler M; Tas P; Firnschild A; Frantz S; Ertl G; Bauersachs J
    Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1071-7. PubMed ID: 15761193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoprenoid depletion by statins antagonizes cytokine-induced down-regulation of endothelial nitric oxide expression and increases NO synthase activity in human umbilical vein endothelial cells.
    Jantzen F; Könemann S; Wolff B; Barth S; Staudt A; Kroemer HK; Dahm JB; Felix SB; Landsberger M
    J Physiol Pharmacol; 2007 Sep; 58(3):503-14. PubMed ID: 17928646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rosuvastatin prevents pressure overload‑induced myocardial hypertrophy via inactivation of the Akt, ERK1/2 and GATA4 signaling pathways in rats.
    Xu X; Zhang L; Liang J
    Mol Med Rep; 2013 Aug; 8(2):385-92. PubMed ID: 23799547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats.
    Hu X; Sun A; Xie X; Huang Z; Jia J; Yao R; Ge J
    J Cardiovasc Pharmacol Ther; 2013 Mar; 18(2):162-76. PubMed ID: 23139358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.